Saurov Mahanta

Dr. Saurov Mahanta

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2022 in Plants
Verified
Journal Article
Open access
PDF file
ANAmilia Nongbet
Amilia Nongbet
Awdhesh Kumar MishraAwdhesh Kumar Mishra
Awdhesh Kumar Mishra
Yugal Kishore MohantaYugal Kishore Mohanta
Yugal Kishore Mohanta
SMSaurov Mahanta
Saurov Mahanta
MRManjit Kumar Ray
Manjit Kumar Ray
Ishani ChakrabarttyIshani Chakrabartty
Ishani Chakrabartty
The widespread use of fertilizers is a result of the increased global demand for food. The commonly used chemical fertilizers may increase plant growth and output, but they have deleterious effects on the soil, the environment, and even human health. Therefore, nanofertilizers are one of the most promising solutions or substitutes for conventional fertilizers. These engineered materials are composed of nanoparticles containing macro- and micronutrients that are delivered to the plant rhizosphere in a regulated manner. In nanofertilizers, the essential minerals and nutrients (such as N, P, K, Fe, and Mn) are bonded alone or in combination with nano-dimensional adsorbents. This review discusses the development of nanotechnology-based smart and efficient agriculture using nanofertilizers that have higher nutritional management, owing to their ability to increase the nutrient uptake efficiency. Additionally, the synthesis and mechanism of action of the nanofertilizers are discussed, along with the different types of fertilizers that are currently available. Furthermore, sustainable agriculture can be realised by the targeted delivery and controlled release of nutrients through the application of nanoscale active substances. This paper emphasises the successful development and safe application of nanotechnology in agriculture; however, certain basic concerns and existing gaps in research need to be addressed and resolved.

21 September 2023 in Agriculture
Verified
Journal Article
Open access
PDF file
MRManjit Kumar Ray
Manjit Kumar Ray
Awdhesh Kumar MishraAwdhesh Kumar Mishra
Awdhesh Kumar Mishra
Yugal Kishore MohantaYugal Kishore Mohanta
Yugal Kishore Mohanta
SMSaurov Mahanta
Saurov Mahanta
Ishani ChakrabarttyIshani Chakrabartty
Ishani Chakrabartty
Ramesh Namdeo PudakeRamesh Namdeo Pudake
Ramesh Namdeo Pudake
It is crucial to increase agricultural yields to fulfill the rising demand for food and the security it provides for a growing population. To protect human food supplies and agricultural outputs, disease management is essential. Plant infections are a silent enemy of economic crop production and cross-border commerce of agricultural goods, inflicting roughly 20–30% losses a year. If infections are accurately and rapidly detected and identified, this can be minimized, and specialized treatment can be given. The current methods of preventing plant diseases are utterly dependent on agrochemicals, which have adverse effects on the ecosystem. By improving their solubility, lengthening their shelf life, and lowering their toxicity, nanotechnology can help reduce the harmful effects of pesticides and fungicides in a sustainable and environmentally responsible way. Engineered nanoparticles can be used to control plant diseases either by using the nanoparticle itself or as a carrier for fungicides and antibiotics. Regardless of the many prospective benefits of using nanoparticles, few nanoparticle-based products have been made commercially available for use in more widespread applications. For rapid and accurate spotting of plant diseases, the combination of nanotechnology systems with molecular diagnostics acts as an alternative where the detection may be taken in on a portable miniaturized appliance. By minimizing the application of chemicals and adopting quick identification of infections, nanotechnology might sustainably minimize many issues in disease control. This review outlines the tools and techniques used in the diagnosis of plant diseases and their management and explains how nanotechnology works, along with the current tools and their prospects for the future of plant protection.

15 April 2021 in Molecular Diversity
Verified
Journal Article
Closed access
PDF file
BGBhaskarjyoti Gogoi
Bhaskarjyoti Gogoi
PCPurvita Chowdhury
Purvita Chowdhury
NGNabajyoti Goswami
Nabajyoti Goswami
NGNeelutpal Gogoi
Neelutpal Gogoi
TNTufan Naiya
Tufan Naiya
PHPratap Jyoti Handique
Pratap Jyoti Handique

21 March 2023 in Molecules
Verified
Journal Article
Open access
PDF file
MSMohammad Zaki Shamim
Mohammad Zaki Shamim
Awdhesh Kumar MishraAwdhesh Kumar Mishra
Awdhesh Kumar Mishra
TKTahreem Kausar
Tahreem Kausar
SMSaurov Mahanta
Saurov Mahanta
BSBhaskar Sarma
Bhaskar Sarma
Yugal Kishore MohantaYugal Kishore Mohanta
Yugal Kishore Mohanta
Diabetes mellitus is a complex illness in which the body does not create enough insulin to control blood glucose levels. Worldwide, this disease is life-threatening and requires low-cost, side-effect-free medicine. Due to adverse effects, many synthetic hypoglycemic medications for diabetes fail. Mushrooms are known to contain natural bioactive components that may be anti-diabetic; thus, scientists are now targeting them. Mushroom extracts, which improve immune function and fight cancer, are becoming more popular. Mushroom-derived functional foods and dietary supplements can delay the onset of potentially fatal diseases and help treat pre-existing conditions, which leads to the successful prevention and treatment of type 2 diabetes, which is restricted to the breakdown of complex polysaccharides by pancreatic-amylase and the suppression of intestinal-glucosidase. Many mushroom species are particularly helpful in lowering blood glucose levels and alleviating diabetes symptoms. Hypoglycaemic effects have been observed in investigations on Agaricussu brufescens, Agaricus bisporus, Cordyceps sinensis, Inonotus obliqus, Coprinus comatus, Ganoderma lucidum, Phellinus linteus, Pleurotus spp., Poria cocos, and Sparassis crispa. For diabetics, edible mushrooms are high in protein, vitamins, and minerals and low in fat and cholesterol. The study found that bioactive metabolites isolated from mushrooms, such as polysaccharides, proteins, dietary fibers, and many pharmacologically active compounds, as well as solvent extracts of mushrooms with unknown metabolites, have anti-diabetic potential in vivo and in vitro, though few are in clinical trials.

25 May 2020 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
SMSaurov Mahanta
Saurov Mahanta
PCPurvita Chowdhury
Purvita Chowdhury
NGNeelutpal Gogoi
Neelutpal Gogoi
NGNabajyoti Goswami
Nabajyoti Goswami
DBDebajit Borah
Debajit Borah
BGBhaskarjyoti Gogoi
Bhaskarjyoti Gogoi
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) which was first reported in Wuhan province of China, has become a deadly pandemic causing alarmingly high morbidity and mortality. In the absence of new targeted drugs and vaccines against SARS-CoV-2 at present, the choices for effective treatments are limited. Therefore, considering the exigency of the situation, we focused on identifying the available approved drugs as potential inhibitor against the promising Coronavirus drug target, the Main Protease, using computer-aided methods. We created a library of U. S. Food and Drug Administration approved anti-microbial drugs and virtually screened it against the available crystal structures of Main Protease of the virus. The study revealed that Viomycin showed the highest -CDocker energy after docking at the active site of SARS-CoV-2 Main Protease. It is noteworthy that Viomycin showed higher -CDocker energy as compared to the drugs currently under clinical trial for SARS-CoV-2 treatment viz. Ritonavir and Lopinavir. Additionally, Viomycin formed higher number of H-bonds with SARS-CoV-2 Main Protease than its co-crystallised inhibitor compound N3. Molecular dynamics simulation further showed that Viomycin embedded deeply inside the binding pocket and formed robust binding with SARS-CoV-2 Main Protease. Therefore, we propose that Viomycin may act as a potential inhibitor of the Main Protease of SARS-CoV-2. Further optimisations with the drug may support the much-needed rapid response to mitigate the pandemic. Communicated by Ramaswamy H. Sarma

11 June 2022 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
Ishani ChakrabarttyIshani Chakrabartty
Ishani Chakrabartty
MKMaryam Khan
Maryam Khan
SMSaurov Mahanta
Saurov Mahanta
HCHITESH CHOPRA
HITESH CHOPRA
Manish DhawanManish Dhawan
Manish Dhawan
TETalha Bin Emran
Talha Bin Emran
From many decades, emerging infections have threatened humanity. The pandemics caused by different CoVs have already claimed and will continue to claim millions of lives. The SARS, Ebola, MERS epidemics and the most recent emergence of COVID-19 pandemic have threatened populations across borders. Since a highly pathogenic CoV has been evolved into the human population in the twenty-first century known as SARS, scientific advancements and innovative methods to tackle these viruses have increased in order to improve response preparedness towards the unpredictable threat posed by these rapidly emerging pathogens. Recently published review articles on SARS-CoV-2 have mainly focused on its pathogenesis, epidemiology and available treatments. However, in this review, we have done a systematic comparison of all three CoVs i.e., SARS, MERS and SARS-CoV-2 along with Ebola and Zika in terms of their epidemiology, virology, clinical features and current treatment strategies. This review focuses on important emerging RNA viruses starting from Zika, Ebola and the CoVs which include SARS, MERS and SARS-CoV-2. Each of these viruses has been elaborated on the basis of their epidemiology, virulence, transmission and treatment. However, special attention has been given to SARS-CoV-2 and the disease caused by it i.e., COVID-19 due to current havoc caused worldwide. At the end, insights into the current understanding of the lessons learned from previous epidemics to combat emerging CoVs have been described. The travel-related viral spread, the unprecedented nosocomial outbreaks and the high case-fatality rates associated with these highly transmissible and pathogenic viruses highlight the need for new prophylactic and therapeutic actions which include but are not limited to clinical indicators, contact tracing, and laboratory investigations as important factors that need to be taken into account in order to arrive at the final conclusion.